Portage Biotech and Immunova sign LOI for potential iOx Therapeutics acquisition

Portage Biotech, Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing innovative therapies to target cancer, has entered into a Letter of Intent (LOI) with Immunova, ... Read More